Clinical proteomics and biomarker discovery

Annals of the New York Academy of Sciences
Donald J JohannLance A Liotta

Abstract

Early detection of disease generally provides much-improved outcomes by a definitive medical procedure or through lifestyle modification along with specific medical management strategies. For serum biomarkers, which are central to the diagnosis of many diseases, to become truly useful sentinels of pathogenesis, their sensitivity and specificity in both early detection and recurrence monitoring must be improved. Currently, the detection and monitoring of disease markers is based on solitary proteins, and this approach is not always reliable. New classes of biomarkers derived from mass spectroscopy analysis of the low molecular weight proteome have shown improved abilities in the early detection of disease and hence in patient risk stratification and outcome. The development of a modular platform technology with sufficient flexibility and design abstractions allowing for concurrent experimentation, test, and refinement will help speed the progress of mass spectroscopy-derived proteomic pattern-based diagnostics from the scientific laboratory to the medical clinic. For acceptance by scientists, physicians, and regulatory personnel, new bioinformatic tools are essential system components for data management, analysis, and intuitive...Continue Reading

References

Nov 17, 2001·JAMA : the Journal of the American Medical Association·L A LiottaE F Petricoin
Feb 28, 2002·Lancet·Emanuel F PetricoinLance A Liotta
Oct 17, 2002·Journal of the National Cancer Institute·Emanuel F PetricoinLance A Liotta
Dec 19, 2002·Molecular & Cellular Proteomics : MCP·N Leigh Anderson, Norman G Anderson
Apr 3, 2003·Nature Reviews. Cancer·Julia D WulfkuhleEmanuel F Petricoin
Jul 25, 2003·Expert Review of Molecular Diagnostics·Thomas P ConradsTimothy D Veenstra
Sep 23, 2003·Clinical Breast Cancer·Antonia VlahouO John Semmes
Oct 31, 2003·Nature·Lance A LiottaEmanuel Petricoin
Feb 6, 2004·Disease Markers·Arpita I MehtaLance A Liotta

❮ Previous
Next ❯

Citations

Dec 14, 2011·Clinical Oral Investigations·Maximilian MoergelBilal Al-Nawas
Dec 24, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Cynthia A AfshariPierre R Bushel
Jan 7, 2005·The FEBS Journal·Julio E CelisPavel Gromov
Mar 23, 2006·Anesthesia and Analgesia·Joshua H Atkins, Jonas S Johansson
Dec 13, 2006·Future Oncology·Zoya R YurkovetskyAnna E Lokshin
Jul 16, 2013·Asian Journal of Andrology·Tao ZhouXue-Jiang Guo
Jul 27, 2005·Proceedings of the National Academy of Sciences of the United States of America·Dobrin NedelkovRandall W Nelson
Jul 10, 2010·Journal of Neuro-oncology·Anja ElstnerAndreas Kurtz
Dec 19, 2006·Critical Reviews in Clinical Laboratory Sciences·Catherine J LeeDavid A Fishman
Jun 9, 2015·International Journal of Molecular Sciences·Wei ZhaoJiaxiang Wang
Jul 8, 2005·Expert Review of Proteomics·Dobrin Nedelkov
Dec 1, 2008·Expert Opinion on Medical Diagnostics·Urban A Kiernan
Feb 4, 2016·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Gianluca ParediAndrea Mozzarelli
Apr 3, 2013·Nature Methods·Allison Doerr
Mar 7, 2013·Auris, Nasus, Larynx·Xia-bing TangGuo-qian Chen
Sep 19, 2007·British Journal of Pharmacology·J CummingsC Dive
Apr 21, 2006·Immunological Reviews·Minnie M Sarwal
Feb 1, 2013·International Journal of Cancer. Journal International Du Cancer·Yong LiuYuanzheng Qiu
Dec 19, 2009·International Journal of Cancer. Journal International Du Cancer·Xi-Xi CaoXiu-Ping Liu
Oct 21, 2006·Clinical Oncology : a Journal of the Royal College of Radiologists·J GrasslG Thomas
Apr 21, 2006·Schizophrenia Research·Jianfeng MeiBarbara Porton
Aug 21, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yong LiuYuanzheng Qiu
Dec 27, 2005·Drug Discovery Today·Jennifer Listgarten, Andrew Emili
Dec 18, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Zhi WangQianming Chen
May 7, 2016·Molecular & Cellular Proteomics : MCP·Ahmed MoghiebKevin K W Wang
Jun 1, 2006·Molecular & Cellular Proteomics : MCP·Dobrin NedelkovRandall W Nelson
Mar 9, 2018·Medical Sciences : Open Access Journal·Ben-Hur Neves de OliveiraFares Zeidán-Chuliá
May 18, 2006·Proteomics·Agasanur K PrahaladJanet M Hock
Sep 1, 2007·Proteomics. Clinical Applications·Rose P Webster, Leslie Myatt
Jul 8, 2005·Expert Review of Proteomics·Visith Thongboonkerd
Jul 26, 2005·Proteomics·Lynne ThadikkaranJean-Daniel Tissot

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.